You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 1, January 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Extract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Surgery, Other
 •Diagnosis
 •Alert me on articles by topic

Image of the Month—Diagnosis


Arch Surg. 2007;142(1):96.

Answer: Pedunculated Hepatocellular Carcinoma

Histopathological findings showed the mass to be a well-differentiated, pedunculated hepatocellular carcinoma (HCC) with regions of necrosis and cystic degeneration. On immunohistochemical analysis, the tumor stained positively for alpha fetoprotein. Excision was complete, with a clear margin of 11 mm within the pedicle.

Pedunculated HCC can be defined as carcinoma protruding from the liver with or without a pedicle and was first described by Roux in 1897.1 It is a rare variant of HCC; more frequently occurring variants are classified as nodular, massive, and diffuse.2 Pedunculated tumors do not differ significantly from HCCs in terms of patient demographics, viral infection, or associated liver disease.3 It has been proposed to subclassify the macroscopic appearances of pedunculated HCC into pedunculated type with a pedicle (subtype I, as is this case) and pedunculated type without a pedicle and attached to the liver surface (subtype II).4

In Japan, pedunculated HCC represents 0.24% to 3.00% of all cases of HCC.5 In the largest published series to date, Yeh et al3 found that 18 (4.2%) of 432 patients with HCC had pedunculated growth. Of the pedunculated HCC group, 11 patients (61%) had well-differentiated histological characteristics and a significantly improved overall survival. The mean survival in the pedunculated group was 94 months, compared with 54.5 months for nonpedunculated HCCs. The pedunculated tumors tended to be larger and to have a more prominent capsule. Although increased tumor size is associated with poorer prognosis in HCC,6 a wider resection margin was obtained with pedunculated tumors despite a tendency for larger tumor size. Yeh et al3 suggest that pedunculated tumors protrude from a pedicle; thus, growth into the liver is limited. Most importantly, the pedunculated tumors exhibited less vascular invasion than did the nonpedunculated HCCs. Vascular invasion is widely accepted as the most consistently reported risk factor for recurrence after resection,7 which likely explains the improved survival seen in patients with pedunculated HCC in that series.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Answer: pedunculated...
 •Author information
 •References

Corresponding Author: Lucy Tzouliadis, MBChB, MRCS, Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke RG24 9NA, England (ltzouliadis{at}hotmail.com).

Accepted for Publication: December 18, 2005.

Author Contributions: Study concept and design: Tzouliadis, Hulin, Shaw, and Rees. Acquisition of data: Tzouliadis. Analysis and interpretation of data: Rees. Drafting of the manuscript: Tzouliadis and Shaw. Critical revision of the manuscript for important intellectual content: Tzouliadis, Hulin, Shaw, and Rees. Administrative, technical, and material support: Tzouliadis and Hulin. Study supervision: Tzouliadis, Hulin, Shaw, and Rees.

Financial Disclosure: None reported.


REFERENCES
 Jump to Section
 •Top
 •Answer: pedunculated...
 •Author information
 •References

1. Roux C. Un cas de cancer primitive du foie avec pericholecystite calculeuse, perforation intestinale: hemostase hepatigue. Rev Med Suisse Romande. 1897;17:114-119.
2. Eggel H. Uber das primare Carcinom der Leber. Betir Pathol Anat Allg Pathol. 1901;30:506-604.
3. Yeh CN, Lee WC, Jeng LB, Chen MF. Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg. 2002;26:1133-1138. FULL TEXT | ISI | PUBMED
4. Nakashima T, Okuda K, Kojiro M; et al. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer. 1983;51:863-877. FULL TEXT | ISI | PUBMED
5. Horie Y, Katoh S, Yoshida H, Imaoka T, Suou T, Hirayama C. Pedunculated hepatocellular carcinoma: report of three cases and review of literature. Cancer. 1983;51:746-751. FULL TEXT | ISI | PUBMED
6. Chen MF, Jeng LB. Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S329-S334. ISI | PUBMED
7. Yamamoto J, Kosuge T, Takayama T; et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219-1222. FULL TEXT | ISI | PUBMED

SECTION EDITOR: GRACE S. ROZYCKI, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.